| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3)
Also Known As:| 1. | Infection
|
| 2. | Glomerulonephritis
|
| 3. | Viremia
|
| 4. | Proteinuria
|
| 5. | Albuminuria
|
| 1. | Paddock, Christopher D: 1 article (05/2007) |
| 2. | Erickson, Bobbie R: 1 article (05/2007) |
| 3. | Nichol, Stuart T: 1 article (05/2007) |
| 4. | Hannafin, Christopher H: 1 article (05/2007) |
| 5. | Pavlin, Boris I: 1 article (05/2007) |
| 6. | Comer, James A: 1 article (05/2007) |
| 7. | Bandy, Utpala: 1 article (05/2007) |
| 8. | Zaki, Sherif: 1 article (05/2007) |
| 9. | Parsely, Melody S: 1 article (05/2007) |
| 10. | Smith, Kathleen A: 1 article (05/2007) |
| 1. | Transplants (Transplant)
05/01/2007
- "Pet rodents and fatal lymphocytic choriomeningitis in transplant patients."
10/15/1969 - "Interaction of graft-versus-host reaction and lymphocytic choriomeningitis infection in mice: histopathological changes." Order ALL the reference details at left... |
| 2. | Homologous Transplantation (Allograft)
04/15/1996
- "Pancreatic TGF-beta1 did not delay allograft rejection, nor did it inhibit autoimmune diabetes after lymphocytic choriomeningitis infection of double transgenic mice (LCMV/TGF-beta1 mice)"
Order ALL the reference details at left... |
| 3. | Immunotherapy
01/01/1964
- "PASSIVE IMMUNOPROPHYLAXIS AND IMMUNOTHERAPY OF INHALATION LYMPHOCYTIC CHORIOMENINGITIS IN GUINEA-PIGS."
Order ALL the reference details at left... |
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |